<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
51079-385-19
</NDCCode>
<PackageDescription>
25 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-385-19) > 1 TABLET in 1 BLISTER PACK (51079-385-17)
</PackageDescription>
<NDC11Code>
51079-0385-19
</NDC11Code>
<ProductNDC>
51079-385
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Carbamazepine
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Carbamazepine
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
19950928
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA070541
</ApplicationNumber>
<LabelerName>
Mylan Institutional Inc.
</LabelerName>
<SubstanceName>
CARBAMAZEPINE
</SubstanceName>
<StrengthNumber>
200
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-12-28
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>